U.S. Veterinary Orthopedic Medicine Market Size & Outlook
Related Markets
U.S. veterinary orthopedic medicine market highlights
- The U.S. veterinary orthopedic medicine market generated a revenue of USD 600.2 million in 2023 and is expected to reach USD 1,009.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.7% from 2024 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating product in 2023.
- Viscosupplements is the most lucrative product segment registering the fastest growth during the forecast period.
Veterinary orthopedic medicine market data book summary
| Market revenue in 2023 | USD 600.2 million |
| Market revenue in 2030 | USD 1,009.0 million |
| Growth rate | 7.7% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Viscosupplements |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics, Viscosupplements, Pharmaceuticals |
| Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Elanco Animal Health Inc, Daiichi Sankyo Co Ltd, Merck & Co Inc, Vetoquinol SA, Ceva Santé Animale, Virbac SA, Biogenesis Bago, Ardent Health Services, Biomerica Inc, PetVivo Holdings, Contipro, Medrego, Hyalogic |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.0% of the global veterinary orthopedic medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. veterinary orthopedic medicine market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 105.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Orthopedic Medicine Market Scope
Veterinary Orthopedic Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hyalogic | View profile | 11-50 | Riverside, Missouri, United States, North America | https://hyalogic.com |
| Medrego | View profile | 1-10 | Riga, Riga, Latvia, Europe | https://www.medrego.com/ |
| Contipro | View profile | - | Dolni Dobrouc, Pardubicky kraj, Czech Republic, Europe | https://www.contipro.com/ |
| PetVivo Holdings | View profile | 11-50 | Edina, Missouri, United States, North America | http://petvivo.com/ |
| Biogenesis Bago | View profile | 501-1000 | Garín, Buenos Aires, Argentina, South America | https://www.biogenesisbago.com/en/ |
| Ceva Santé Animale | View profile | 5001-10000 | Libourne, Aquitaine, France, Europe | https://www.ceva.us |
| Ardent Health Services | View profile | 10001+ | Nashville, Tennessee, United States, North America | http://ardenthealth.com |
| Daiichi Sankyo Co Ltd | View profile | 17435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | https://www.daiichisankyo.com |
| Biomerica Inc | View profile | 62 | 17571 Von Karman Avenue, Irvine, CA, United States, 92614 | https://www.biomerica.com |
| Vetoquinol SA | View profile | 2483 | Magny-Vernois, BP 189, Lure cedex, France, 70204 | http://www.vetoquinol.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Elanco Animal Health Inc | View profile | 9800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | https://www.elanco.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Virbac SA | View profile | 5400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | https://www.virbac.com |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
U.S. veterinary orthopedic medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary orthopedic medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 46.72% in 2023. Horizon Databook has segmented the U.S. veterinary orthopedic medicine market based on biologics, viscosupplements, pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The key driver responsible for the U.S. market growth is rising prevalence of osteoarthritis and other degenerative joint diseases. According to an article published by Morris Animal Foundation, in October 2023, osteoarthritis affects around 14 million adult dogs in the U.S., making it a major health problem for dog owners.
Although exact percentages for cats are still unknown, X-rays show that 90% of cats older than 12 have osteoarthritis. These figures demonstrate a significant amount of animals suffering from this illness. Chronic osteoarthritis is a joint condition resulting in pain and limb impairment.
It is identified by the formation of new bone known as osteophytosis surrounding the joint, thickening of the joint capsule, and loss of joint cartilage. Most canine osteoarthritis is caused by developmental orthopedic diseases, such as cranial cruciate ligament disease, elbow dysplasia, hip dysplasia, dislocation of the patella (kneecap), and OCD.
Reasons to subscribe to U.S. veterinary orthopedic medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. veterinary orthopedic medicine market databook
-
Our clientele includes a mix of veterinary orthopedic medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary orthopedic medicine market, including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary orthopedic medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. veterinary orthopedic medicine market report size, by biologics, 2018-2030 (US$M)
U.S. Veterinary Orthopedic Medicine Market Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
